.png?resize=410x0)
AQVESME (which many may previously have known as mitapivat) was recently approved by the FDA for use in the U.S. in both…
.png?resize=410x0)
The Cooley’s Anemia Foundation (CAF) is proud to announce a new program to assist U.S. thalassemia patients with f…
We’re proud to announce five new Cooley’s Anemia Foundation Medical Research Fellowships for the 2025-2026 g…
*IMPORTANT: The following information is a press release that has been released in advance of the date being presented f…
The recent death of an adult with thalassemia, apparently from sepsis (overwhelming bacterial infection) has led to some…
CAF recently learned of a Thalassemia patient with a kidney problem called Renal Fanconi Syndrome, likely due to deferas…
For over 70 years, the Cooley's Anemia Foundation, a 501(c)(3) nonprofit organization, has been a strong and supportive partner for families living with Thalassemia.
